Search

everythinglearnresearchcommunity

for

Search:↓

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

New treatments for PCOS focus on managing symptoms and improving fertility.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

PCOS may increase the risk of high blood pressure and heart issues.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Women with PCOS often experience mental health issues like depression and anxiety.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Women with PCOS have higher cardiometabolic risks.

Metformin reduces high male hormone levels in women with PCOS.

These ovarian conditions cause high testosterone levels.

H. pylori infection may be linked to insulin resistance in women with PCOS.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

Certain gene variations may increase the risk of PCOS in South Indian women.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.